-- Milestone marks first of multiple planned diagnostic product launches on NGS roadmap -- Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro ...

IDT's suite of NGS innovations aim to tackle longstanding bottlenecks in library preparation, targeted enrichment, and whole ...

New innovations designed to simplify NGS workflows Enhances critical variant identification through improved technologies Roadmap advances provide flexibility across targeted and whole genome ...

Most DNA extraction protocols were originally developed for manual pipetting and later adapted for liquid handlers. In ...

The global DNA sequencing market is projected to reach USD 40.02 billion by 2031, driven by declining sequencing costs, expanding clinical applications in oncology and rare diseases, and growing ...

For more than three decades, Integrated DNA Technologies (IDT) has helped power the genomics revolution, enabling scientists to decode biology with growing precision and speed. Today, as cancer ...

Oncology leaders appearing in Atlanta, Georgia, including several from Winship Cancer Institute from Emory University School of Medicine, show how NGS biomarkers and MRD reshape NSCLC and hematology ...

OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc.

Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this ...

After years of operating in the research markets, IDT has launched IVD assays based on the core chemistry capabilities from the company's Archer portfolio.

Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...